Roma patients with MetS have higher levels of hs-CRP (high sensitivity C-reactive protein) and GGT (gamma-glutamyl transpeptidase), which is a surrogate marker for fatty liver disease [31,32,33]. This evidence concerns the gene GGTLC1 and fatty liver disease.